Association of LDL-cholesterol subfractions with cardiovascular disorders: a systematic review

被引:0
|
作者
Abdolreza Chary
Maryam Tohidi
Mehdi Hedayati
机构
[1] Shahid Beheshti University of Medical Sciences,Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences
[2] Shahid Beheshti University of Medical Sciences,Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences
来源
BMC Cardiovascular Disorders | / 23卷
关键词
Low-density lipoprotein; Cholesterol; LDL subclasses; Small dense LDL; Cardiovascular Disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Effects of BMI and LDL-cholesterol change pattern on cardiovascular disease in normal adults and diabetics
    Youk, Tae Mi
    Kang, Min Jin
    Song, Sun Ok
    Park, Eun-Cheol
    BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (02)
  • [22] Effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults
    Oelrich, B.
    Dewell, A.
    Gardner, C. D.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2013, 23 (04) : 350 - 357
  • [24] Addressing dyslipidemic risk beyond LDL-cholesterol
    Tall, Alan R.
    Thomas, David G.
    Gonzalez-Cabodevilla, Ainara G.
    Goldberg, Ira J.
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (01)
  • [25] Cognition After Lowering LDL-Cholesterol With Evolocumab
    Gencer, Baris
    Mach, Francois
    Guo, Jianping
    Im, KyungAh
    Ruzza, Andrea
    Wang, Huei
    Kurtz, Christopher E.
    Pedersen, Terje Rolf
    Keech, Anthony C.
    Ott, Brian R.
    Sabatine, Marc S.
    Giugliano, Robert P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (18) : 2283 - 2293
  • [27] Genetically instrumented LDL-cholesterol lowering and multiple disease outcomes: A Mendelian randomization phenome-wide association study in the UK Biobank
    Pham, Kitty
    Mulugeta, Anwar
    Lumsden, Amanda
    Hypponen, Elina
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (10) : 2992 - 3004
  • [28] Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment
    Carr, Stuart S.
    Hooper, Amanda J.
    Sullivan, David R.
    Burnett, John R.
    PATHOLOGY, 2019, 51 (02) : 148 - 154
  • [29] LDL-cholesterol reduction in chronic kidney disease: options beyond statins
    Goonasekera, Michelle A.
    Mafham, Marion M.
    Haynes, Richard J.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2020, 29 (05) : 480 - 488
  • [30] Evaluation of a homogeneous assay for measuring LDL-cholesterol in hyperlipiclemic serum specimens
    Yamashita, Shizuya
    Nakamura, Mitsuhiro
    Koizumi, Hiroaki
    Oku, Hiroyuki
    Sandoval, Jose C.
    Tsubakio-Yamamoto, Kazumi
    Kawase, Miyako
    Masuda, Daisaku
    Koseki, Masahiro
    Matsuura, Fumihiko
    Shimomura, Iichiro
    Nishida, Makoto
    Ishigami, Masato
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2008, 15 (02) : 82 - 86